tyrosyl-arginyl-phenylalanyl-lysinamide and Inflammatory Bowel Diseases

tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with Inflammatory Bowel Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breisse, M; Bulois, P; Chakass, D; Chamaillard, M; Colombel, JF; Desreumaux, P; Gay, J; Geboes, K; Philippe, D; Thuru, X; Tsicopoulos, A; Vorng, H; Zerbib, P	1

Other Studies

1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and Inflammatory Bowel Diseases

Article	Year
Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. Gut, 2006, Volume: 55, Issue:6 Topics: Adult; Analgesics, Opioid; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Colitis, Ulcerative; Colon; Crohn Disease; Cytokines; Female; Homeostasis; Humans; Ileum; Inflammatory Bowel Diseases; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Middle Aged; Oligopeptides; Receptors, Opioid, mu; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2006

Article

Year

Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

Gut, 2006, Volume: 55, Issue:6

Topics: Adult; Analgesics, Opioid; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Colitis, Ulcerative; Colon; Crohn Disease; Cytokines; Female; Homeostasis; Humans; Ileum; Inflammatory Bowel Diseases; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Middle Aged; Oligopeptides; Receptors, Opioid, mu; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2006